Here are six things to know:
1. The shares were sold at an average price of $104.99, for a total of $1.25 million.
2. Ms. Stryker now directly owns 193,142 shares of the company.
3. The stock presently has a consensus rating of “hold” and a consensus price target of $101.05.
4. Stryker has a 12-month low of $86.68 and a 12-month high of $105.95.
5. The company’s 50-day moving average price is $101.43 and its 200-day moving average price is $96.96.
6. The company’s stock has a market cap of $39.04 billion.
More articles on devices:
SpineCraft shows 4 technologies at AANS/CNS Spine Summit
Carestream introduces cone beam CT system for orthopedic practitioners — 4 insights
Anika’s CINGAL receives CE Mark approval — 5 highlights
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
